<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20180604039980N2</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2021-03-21</date_registration>
      <primary_sponsor>Shiraz University of Medical Sciences</primary_sponsor>
      <public_title>Standalone vertebroplasty versus posterior spinal fixation</public_title>
      <acronym></acronym>
      <scientific_title>Clinical and radiological outcomes of standalone polymethylmethacrylate vertebroplasty versus posterior spinal fixation in the treatment of patients with thoracolumbar burst fractures</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2021-04-09</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>52</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/54508</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Other design features: Fifty-two patients with thoracolumbar burst fractures are eligible for participation. The patients will randomly be allocated to two groups: group A or vertebroplasty (n=26), and group B or pedicular screw fixation (n=26), Randomization description: We will perform a prospective single-blind, randomized case-controlled trial in which 52 patients with thoracolumbar burst fractures will be enrolled. A general practitioner not only will assess 52 patients for eligibility, but also will evaluate baseline characteristics of eligible patients before randomization. Written informed consent will be obtained from all patients before operation. Eligible participants will be randomly assigned to two groups by opening sealed envelopes. The envelopes will be prepared beforehand and sorted randomly by using random allocation software (computerized random number generators). Randomization will be performed by a neurosurgery resident after the inclusion of the patients into the study by the surgeon. The patient will draw one of the two envelopes indicating surgical treatment with either Standalone Polymethylmethacrylate Vertebroplasty or Posterior Spinal. The patients will be randomly allocated to one of two groups: 
group I: standalone percutaneous cement augmentation in the fractured level(s)
group II: posterior pedicular screw fixation in the fractured level(s), Blinding description: The data analysts and evaluators will be blind in this study, therefore it will be a single-blind study.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Clinical and radiological outcomes of standalone polymethylmethacrylate vertebroplasty versus posterior spinal fixation in the treatment of Patients with thoracolumbar burst fractures.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group:  standalone polymethylmethacrylate vertebroplasty  in the treatment of patients with thoracolumbar burst fractures. Intervention 2: Intervention group: posterior spinal fixation in treatment  in the treatment of patients with thoracolumbar burst fractures.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Standalone polymethyl methacrylate (PMMA) vertebroplasty versus posterior spinal fixation in the treatment of burst thoracolumbar fractures with regard to clinical and radiologic outcomes.
Radiologic outcomes include postoperative angulation and the correction of height reduction.  The severity of postoperative pain is evaluated using the VAS.quality of life (QOL) is evaluated by a questionnaire based on the Oswestry Disability Index (ODI).

When:
After the publication of the results.

To whom:
All readers

Conditions:
All data of the patients will be available to the corresponding author of this proposal. For any query on the data of the patients in this study, you can contact Shiraz Neuroscience Research Center and pose your request to the corresponding author of this study.

Where to obtain:
Shiraz Neuroscience Research Center

How to obtain:
Contact Shiraz Neuroscience Research Center

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Dr. Majid Reza Farrokhi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Shiraz Neurosciences Research Center, Chamran Hospital, Chamran Blvd., Shiraz</address>
        <city>Shiraz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7194815644</zip>
        <telephone>+98 71 3623 4508</telephone>
        <email>farrokhimr@yahoo.com</email>
        <affiliation>Shiraz University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Dr. Majid Reza Farrokhi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Shiraz Neurosciences Research Center, Chamran Hospital, Chamran Blvd., Shiraz</address>
        <city>Shiraz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7194815644</zip>
        <telephone>+98 71 3623 4508</telephone>
        <email>farrokhimr@yahoo.com</email>
        <affiliation>Shiraz University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Traumatic fracture
Age between 18 to 65 years
Burst fracture (40-60% height reduction, 20-40% canal compromise, kyphotic angulation 20 to 40 degrees)
Hemodynamic stability
Fracture below T6 level
Fracture in the last 2 weeks
Intact neurological exam
One or two level fractures</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>65 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria></exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>S22.001A</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Stable burst fracture of unspecified thoracic vertebra, initial encounter for closed fracture</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Surgery</i_code>
      <i_code>Treatment - Surgery</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group:  standalone polymethylmethacrylate vertebroplasty  in the treatment of patients with thoracolumbar burst fractures</i_keyword>
      <i_keyword>Intervention group: posterior spinal fixation in treatment  in the treatment of patients with thoracolumbar burst fractures</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Spinal kyphosis. Timepoint: Preoperatively, early postoperatively and at 2 and 6 months after the surgery. Method of measurement: Measure the degree of spinal angulation.</prim_outcome>
      <prim_outcome>Vertebral height. Timepoint: Preoperatively, early postoperatively and at 2 and 6 months after the surgery. Method of measurement: Measure the vertebral height.</prim_outcome>
      <prim_outcome>Pain measurement. Timepoint: Two and six months after the operation. Method of measurement: The pain VAS (Visual Analogue Scale) is a unidimensional measure of pain intensity.</prim_outcome>
      <prim_outcome>Low back pain disability measurement. Timepoint: Six months after the operation. Method of measurement: For measuring the ow back pain disability, the Oswestry Disability Index (ODI) is used.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Pain score according to VAS (Visual Analogue Scale). Timepoint: Two and six months after the operation. Method of measurement: The Visual Analogue Scale (VAS) consists of a straight line with the endpoints defining extreme limits such as "no pain at all" and "pain as bad as it could be". The patient is asked to mark his pain level on the line between the two endpoints. The distance between "no pain at all" and the mark then defines the subject’s pain.</sec_outcome>
      <sec_outcome>Oswestry Disability Index (ODI). Timepoint: Six months after the operation. Method of measurement: The Oswestry Disability Index (ODI) is an index derived from the Oswestry Low Back Pain Questionnaire used by clinicians and researchers to quantify disability for low back pain.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Shiraz University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2019-05-08</approval_date>
        <contact_name>Ethics committee of Shiraz University of Medical Sciences</contact_name>
        <contact_address>Central Building of Shiraz University of Medical Sciences, Zand Blvd., Shiraz Shiraz Fars Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
